HIGHLIGHTS
- who: MDPI from the censee MDPI, Basel, SwitzerlandDepartment of Neuroscience, School of Medicine, University of Minnesota, Minneapolis, MN, USA have published the research: Protein Kinase CK2 and Its Potential Role as Therapeutic Target in Huntington's Disease, in the Journal: Biomedicines 2022, 10, 1979. of /2022/
- what: The molecules that regulate PTMs show promise as potential therapeutic targets as an alternative to aforementioned approaches that are focused on mtHTT lowering via ASOs or small_molecules targeting HTT RNA_splicing . The study of HTT PTMs has been primarily focused on the first 17 amino_acids on the N‐terminal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.